Zhongzhi Pharmaceutical Holdings (HKSE:03737) Equity-to-Asset : 0.59 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Zhongzhi Pharmaceutical Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,147 Mil. Zhongzhi Pharmaceutical Holdings's Total Assets for the quarter that ended in Dec. 2023 was HK$1,961 Mil. Therefore, Zhongzhi Pharmaceutical Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.59.

The historical rank and industry rank for Zhongzhi Pharmaceutical Holdings's Equity-to-Asset or its related term are showing as below:

HKSE:03737' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.41 Med: 0.59 Max: 0.78
Current: 0.59

During the past 10 years, the highest Equity to Asset Ratio of Zhongzhi Pharmaceutical Holdings was 0.78. The lowest was 0.41. And the median was 0.59.

HKSE:03737's Equity-to-Asset is ranked better than
51.61% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs HKSE:03737: 0.59

Zhongzhi Pharmaceutical Holdings Equity-to-Asset Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Equity-to-Asset Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.60

0.58

0.59

0.54

0.59

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.59	0.63	0.54	0.60	0.59

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongzhi Pharmaceutical Holdings's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Equity-to-Asset falls into.

Zhongzhi Pharmaceutical Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Zhongzhi Pharmaceutical Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1146.845	/	1960.746
	=	0.58

Zhongzhi Pharmaceutical Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1146.845	/	1960.746
	=	0.58

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Zhongzhi Pharmaceutical Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Equity-to-Asset

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Headlines

No Headlines